Biosite has acquired Construct Technology to further strengthen its range of services for the sector.
Construct Technology have developed a mobile system that delivers time and costs savings for construction site managers.
The Construct mobile app offers project managers specific project management and BIM collaboration tools.
It allows cross-site and multi–location real time information management which means everyone on or off-site is up to date, all of the time.
The Construct app also keeps sites compliant, with a paperless audit trail that streamlines process milestones, sign offs and handovers.
Biosite provides access control and workforce management solutions for construction sites.
Recently they have extended their product portfolio to give customers a complete integrated solution, to help manage, monitor and maximise safety and security on their sites.
This new acquisition is another asset to the product range.
Anthony Erwin at Construct Technology, said “When our range of app-based products are combined with Biosite’s biometric access control system, it becomes one of the most powerful and comprehensive workforce management tools on the market today.
“Biosite is a perfect company to take our business to the next level and was the ideal choice to exploit our products with. Their own algorithm for fingerprint recognition is one of the best in the world and the fact that they also develop all their software and hardware in-house became a really exciting proposal for us.”
Li Wang, managing director of Biosite, said: “Construct Technology was an obvious partner for our business, as better use of data and reducing paperwork will directly help the productivity of our construction sector customers.
“This acquisition will allow us to further improve our technology, helping us have a positive impact on safety for those working in the construction industry.”
from Construction Enquirer http://www.constructionenquirer.com/2018/12/18/biosite-buys-site-manager-app-specialist/
via Tumblr http://ndbasilica.tumblr.com/post/181230020129
No comments:
Post a Comment